To escape the action of TRAIL produced from tumor microenvironments, cancer cells develop resistance to TRAIL through multiple mechanisms, including reducing the expression of TRAIL receptors, increasing the expression of TRAIL decoy receptors or disrupting the effectors downstream of TRAIL signaling [4]. The gene discussed is TNFSF10; the disease is cancer.